Opinion for the Court filed by Circuit Judge SENTELLE.
Jon Gettman and High Times Magazine petition this Court for review of the March 20, 2001 decision of the Drug Enforcement Administration (“DEA”) denying their petition to initiate rulemaking proceedings to reschedule marijuana under 21 U.S.C. § 811(a). See Drug Enforcement Administration Notice of Denial of Petition, 66 Fed.Reg. 20038 (April 18, 2001). The DEA contends we should dismiss the petition for review, arguing that neither Gett-man nor High Times Magazine has standing to bring this petition. Because we agree with the DEA, we dismiss the petition.
*432 I. Background
The Controlled Substances Act, 21 U.S.C. § 801, et seq., sets forth initial schedules of drugs and controlled substances in 21 U.S.C. § 812(c). However, Congress established procedures for adding or removing substances from the schedules (control or decontrol), or to transfer a drug or substance between schedules (reschedule). 21 U.S.C. § 811(a). This responsibility is assigned to the Attorney General in consultation with the Secretary of Health and Human Services (“HHS”). Id. § 811(b). The Attorney General has delegated his functions to the Administrator of the DEA. 28 C.F.R. § 0.100(b). Current schedules are published at 21 C.F.R. §§ 1308.11-1308.15.
There are three methods by which the DEA may initiate rulemaking proceedings to revise the schedules: (1) by the DEA’s own motion; (2) at the request of HHS; (3)on the petition of any interested party. 21 U.S.C. § 811(a); 21 C.F.R. § 1308.43(a). Before initiating rulemaking proceedings, the DEA must request a scientific and medical evaluation from HHS and a recommendation. The statute requires the DEA and HHS to consider eight factors with respect to the drug or controlled substance. 21 U.S.C. § 811(b), (c). These factors are:
(1) Its actual or relative potential for abuse.
(2) Scientific evidence of its pharmacological effect, if known.
(3) The state of current scientific knowledge regarding the drug or other substance.
(4) Its history and current pattern of abuse.
(5) The scope, duration, and significance of abuse.
(6) What, if any, risk there is to the public health.
(7) Its psychic or physiological dependence liability.
(8) Whether the substance is an immediate precursor of a substance already controlled under this subchapter.
21 U.S.C. § 811(c). Although the recommendations of HHS are binding on the DEA as to scientific and medical considerations involved in the eight-factor test, the ultimate decision as to whether to initiate rulemaking proceedings to reschedule a controlled substance is made by the DEA. See id. § 811(a), (b).
Jon Gettman petitioned the DEA in 1995 to initiate rulemaking proceedings under 21 U.S.C. § 811(a) to reschedule various controlled substances, including marijuana. Subsequently High Times Magazine joined with him as a petitioner. In their petition to DEA, Gettman and High Times claimed that “there is no scientific evidence that [marijuana has] sufficient abuse potential to warrant schedule I or II status” under the Controlled Substances Act. In accordance with 21 U.S.C. § 811(b), the DEA forwarded the petition to HHS in 1997. In 2001, HHS recommended that marijuana remain in schedule I and the DEA in turn denied the petition. No action has been taken regarding the other drugs initially named by Gettman.
Gettman and High Times filed this petition for review of the DEA’s refusal to initiate rulemaking proceedings to reschedule marijuana. On our own motion, we ordered supplemental briefing on standing, and specifically asked parties to address the issue of injury.
II. Analysis
Article III, section 2, clause 1 of the United States Constitution limits the “judicial power” of the United States to the resolution of “cases” or “controversies.”
Valley Forge Christian College v. Americans United for Separation of
*433
Church & State, Inc.,
A. Standing as an “Interested Party”
Petitioners contend that they have “automatic standing” to appeal the DEA’s denial of their petition because 21 U.S.C. § 811(a)(2) permits “any interested party” to file a petition to initiate rulemaking proceedings. They suggest that this is enough — since they are the original petitioners before the DEA they should not be “held to heightened requirements for standing in pursuing judicial review of the DEA’s order,” and at no time during the administrative proceedings has the DEA claimed that they are not “interested parities]” under 21 U.S.C. § 811(a)(2). Petitioners misunderstand the law. Petitioners may be “interested part[ies]” under the statute, and therefore able to petition the agency, and yet not have Article III standing to bring this action in federal court.
See Fund Democracy, LLC v. SEC,
Therefore, contrary to petitioners’ suggestion, it is not at all anomalous that Congress could permit them as “interested part[ies]” (assuming that they are) to participate in agency proceedings, and yet they be unable to seek review in the federal courts. “Because agencies are not constrained by Article III, they may permit persons to intervene in the agency proceedings who would not have standing to seek judicial review of the agency action.”
Fund Democracy,
B. Injury In Fact
Petitioners bear the burden of establishing an injury in fact.
See Lujan,
Petitioner Gettman argues that he will suffer “economic or competitive injury” from the DEA’s decision not to initiate a rescheduling rulemaking for marijuana because he is “a public policy professional qualified to research, advise, invest, and profit from the development of medical marijuana.” Gettman asserts that the schedule I classification of marijuana constrains his “ability to research economic development in this area and to sell his services' as a policy analyst and/or professor.” ■ Thus, Gettman contends that the DEA’s order has caused him injury “by narrowing the universe of customers of consulting services and also by stymieing his ability to legally conduct clinical and social research on marijuana, its effects and medical utility.” Gettman’s recitation of his interest and the injury to it fall far short of establishing a judicially protected interest or a judicially remediable injury. His desire to achieve vague objectives with relation to marijuana and his supposition that the DEA’s failure to take the action he requested will retard the achievement of those goals does not cross the Article III threshold. “[A] mere ‘interest in a problem,’ no matter how longstanding the interest and no matter how qualified the organization is in evaluating the problem, is not sufficient by itself....”
Sierra Club v. Morton,
Completing the inadequacy of Gettman’s argument is the purely speculative nature of the harm and its remediability. There is no way to know whether anyone would beat a path to Gettman’s door were the DEA to begin the reevaluation of marijuana. This sort of speculative claim falls far short of establishing the “core constitutional component that a plaintiff must allege.”
Allen v. Wright,
In Simon, Allen v. Wright, and numerous other cases, the courts have reiterated that such speculative claims dependent upon the actions of third parties do not create standing for the purposes of establishing a case or controversy under Article III. In short, Gettman has set forth a speculative injury dependent upon the conduct of third parties not before the court, at best reciting injury to his philosophical interest. We wish to make clear once again what the Supreme Court has long dictated:
Recognition of standing in such circumstances would transform the federal courts into “no more than a vehicle for the vindication of the value interests of concerned bystanders” ... Constitutional limits on the role of the federal courts precludes such a transformation.
Allen v. Wright,
With respect to High Times Magazine, petitioners argue that it has associational standing to bring this action. That theory fails. “An association only has standing to bring suit on behalf of its
members
when its
members
would otherwise have standing to sue in their own right, the interests it seeks to protect are germane to the organization’s purpose, and neither the claim asserted nor the relief requested requires the participation of individual members in the lawsuit.”
Fund Democracy,
Petitioners’ off-hand assertion that the magazine itself has suffered direct injury insofar as the schedule I status of marijuana creates a “chilling effect” on its First Amendment rights to investigate and report on the “medical and cultural realities of marijuana” is unexplained and probably unexplainable. Granted, “[t]he Constitution gives significant protection from over-
*436
broad laws that chill speech within the. First Amendment’s vast and privileged sphere.”
Ashcroft v. Free Speech Coalition,
— U.S.-,-,
Finally, petitioners contend that this Court and others have permitted the filing of petitions for review of DEA orders by parties who were “similarly situated to Jon Gettman and High Times Magazine,” and-for that reason, their petition should be heard.
See NORML v. DEA,
III. Conclusion
Because petitioners Gettman and High Times Magazine lack standing to bring, this petition for review of the DEA’s decision, we dismiss the petition for review. It is
So ordered.
